ESG

A new partnership in Northeast Ohio allows health plan members to buy nutritious groceries with a simple card swipe, turning local stores into health hubs.

Pfizer projects lower 2026 earnings as COVID sales wane and patents expire, shifting focus to a multi-billion dollar R&D push for future growth.

The world's largest bamboo resort opens in a Vietnamese heritage site, blending Hmong culture with advanced wellness for a new kind of regenerative travel.

A new partnership between Beacon Biosignals and Harmony Biosciences will use AI to objectively measure sleepiness, offering new hope for hypersomnia patients.

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

Subsea 7 has landed a contract worth up to $300M for Chevron's Gorgon Stage 3 project, reinforcing its key role in Australia's deepwater energy sector.

A new energy storage system just passed an unprecedented fire test, raising safety standards and building trust in the technology powering our future.

Zephyrus Innovations just got FDA clearance for VaporShield, a device protecting nurses from drug exposure. It’s a story of safety, market disruption, and efficiency.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

A new Google-TotalEnergies deal in Malaysia reveals the collision of a data boom and green energy goals, a key test for the region's strategic future.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

A Chinese startup's tiny new heart pump enters human trials, aiming to disrupt a billion-dollar market and solve a massive unmet need in cardiac care.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

New rankings name Germany's top cancer hospitals, but the real story is the rise of platforms shaping a multi-billion dollar global health market.

NineDot Energy is leveraging battery storage to deliver $60M in energy credits, tackling NYC's affordability crisis and retiring polluting power plants.